I-BremelanotideiwukwenziwaI-melanocortin receptor agonisteyenzelwe ukwelashwa kwei-hypoactive sex desire disorder (HSDD) in abesifazane be-premenopausal. Njengokwelashwa kokuqala okusebenzayo okugunyazwe ngokukhethekile i-HSDD, i-Bremelanotide imele intuthuko enkulu empilweni yobulili yabesifazane.
Kugunyazwe yi-US FDA ngo-2019 ngaphansi kwegama lomkhiqizoVyleesi, I-Bremelanotide inikeza isixazululo esidingeka kakhulu, esingelona ama-hormone kwabesifazane ababhekene nokuntula isifiso socansi okuphikelelayo, esingenakuchazwa ngezinkinga zezokwelapha, ezingokwengqondo, noma zobudlelwane.
EyethuI-Bremelanotide APIikhiqizwa ngokusebenzisa i-solid-phase peptide synthesis (SPPS), iqinisekisa ukuhlanzeka okuphezulu, ukungcola okuphansi, kanye nokuvumelana okulungele imijovo yomtholampilo neyezohwebo.
I-Bremelanotide isebenza ngeivuselela ama-melanocortin receptors, ikakhulukaziI-MC4R (i-melanocortin-4 receptor)kweisimiso sezinzwa esiphakathi. Lokhu kuvula kukholelwa ukuthi kuguqula izindlela ku-i-hypothalamusezihilelekile ekuvukeni nasekufisweni kobulili.
Imithelela ebalulekile ihlanganisa:
Kuthuthukisiweisibonakaliso se-dopaminergic, ukukhuthaza isithakazelo socansi
Ukucindezelwa kwezindlela zokuvimbela ezithinta i-libido
Ukuguqulwa kwesistimu yezinzwa ephakathingaphandle kokuthembela kumahomoni ocansi (non-estrogenic, non-testosterone)
Lo mshini wenza i-Bremelanotide ihluke ekwelashweni kwamahomoni endabuko futhi ifanele abantu besifazane abaningi.
I-Bremelanotide ihlolwe ngokuphindaphindiweIsigaba sesi-2 nesigaba sesi-3 sokuhlolwa komtholampilo, okubandakanya izinkulungwane zabesifazane abatholakala bene-HSDD.
Okutholakele okubalulekile kuhlanganisa:
Ukuthuthukiswa okuphawulekayo ngokwezibalokumaphuzu esifiso socansi (akalwa yi-FSFI-d)
Ukunciphisa ukucindezeleka okuhlobene nesifiso esiphansi socansi (kukalwa yi-FSDS-DAO)
Ukuqala kwesenzo esisheshayo(kungakapheli amahora), ukuvumelaukusetshenziswa okudingekayo ngaphambi kokwenza ucansi
Kuboniswe ukusebenza ngempumelelo kwabesifazanenezimo ezihambisanayo nezingenayo(isb, ukudangala, ukukhathazeka)
Ezifundweni zomtholampilo, kuze kufike25%–35%yeziguli bathole ukuthuthuka okunengqondo uma kuqhathaniswa ne-placebo.
Imiphumela emibi kakhulu ihlanganisaisicanucanu, ukushaywa umoya, futhiikhanda elibuhlungu- ngokuvamile imnene futhi iyazibekela imingcele.
Ngokungafani nama-melanocortin angaphambilini, i-Bremelanotide injalookungahlotshaniswa nokwenyuka okuphawulekayo komfutho wegazi noma izinga lokushaya kwenhliziyoezigulini eziningi.
Njengokwelashwa okudingeka kakhulu, kugwema ukuchayeka kwehomoni okungapheli futhi kungasetshenziswa ngokuguquguquka.
EyethuI-Bremelanotide API:
Ihlanganiswa kusetshenziswa i-SPPS ethuthukisiwe esebenza kahle kakhulu
Ihlangabezana nezindinganiso zamazwe ngamazwe eziqinile zeubumsulwa, ubuwena, nezincibilikisi eziyinsalela
Ilungele ukwakhiwa komjovo (njengamapeni e-autoinjector agcwaliswe ngaphambili)
Itholakala kuamaqoqo okuhlola kanye nezikali zezentengiselwano, esekela kokubili i-R&D kanye nokuhlinzekwa kwemakethe
Ngaphandle kwe-HSDD, indlela ye-Bremelanotide ibangele isithakazelo kwezinye izindawo zeubulili kanye neuroendocrine modulation, okuhlanganisa:
Ukungasebenzi kahle kocansi kwabesilisa
Izifo ezihlobene nemizwa
Ukulawulwa kokudla kanye namandla (ngesistimu ye-melanocortin)
Iphrofayili yayo ye-peptide enesimo esihle kanye nomsebenzi wezinzwa ophakathi kuyaqhubeka nokusekela ukuthuthukiswa okungenzeka ezindaweni eziseduze zokwelapha.